Fiskars announced a profit warning on 12 June, and now expects adjusted EBIT of EUR 90-110m for 2025...
Bridgepoint invests in Safe Life Implied valuation +15% vs.
Redeye comments on yesterday’s news that AlzeCure has received positive feedback from the FDA regard...
After market close, Fiskars announced, what we view as, a severe profit warning.
Redeye provides a comment on this week’s news flow, with new data on BI-1206 in solid tumours and BI...
Prostatype räknar i en uppdaterad bedömning med att granskande part ska återkomma under 2025 med ett...
Karin Schreil, CEO, leaves her position at the end of 2025 She has implemented significant internal ...
Redeye comments on Fable Media Group’s announcement that it has initiated procedures to enable quart...
Redeye comments on Annexin's Q1 report and recent events in the company.
PTS has published new statistics for the SE fibre market BRE2 market share: 14% vs 13% in 2023 BRE2'...
Endomines published its updated strategy for 2025–2029, which largely builds on the previous one, wi...
Redeye is positive about Iconovo’s progress in the GLP-1 space and notes that the development timeli...
Redeye comments on Monday’s milestone payment of SEK12m from Infiniteria.
The fast-track designation from the FDA in metastatic pancreatic cancer confirms Cantargia's strateg...
Redeye comments on Xbrane following its SEK240m directed share issue targeting both institutional an...
Scanfil buys 80% of the US based subcontractor ADCO Circuits.
Redeye initiates coverage of Xplora, a fast-growing family IoT company with a proven recurring reven...
Systemair redovisar ett stabilt fjärde kvartal 2024/25 med förbättrade marginaler och starkt kassafl...
Redeye provides an update following the Q1 report, which came in largely in line with our expectatio...
